Clinical triage of patients on kidney replacement therapy presenting with COVID-19: an ERACODA registry analysis.

ABSTRACT:

Background

Patients on kidney replacement therapy (KRT) are at very high risk of coronavirus disease 2019 (COVID-19). The triage pathway for KRT patients presenting to hospitals with varying severity of COVID-19 illness remains ill-defined. We studied the clinical characteristics of patients at initial and subsequent hospital presentations and the impact on patient outcomes.

Methods

The European Renal Association COVID-19 Database (ERACODA) was analysed for clinical and laboratory features of 1423 KRT patients with COVID-19 either hospitalized or non-hospitalized at initial triage and those re-presenting a second time. Predictors of outcomes (hospitalization, 28-day mortality) were then determined for all those not hospitalized at initial triage.

Results

Among 1423 KR

SUBMITTER: Mitra S 

PROVIDER: S-EPMC8420614 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature